Sutton Wealth Advisors’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$2.93K Buy
43
+16
+59% +$1.26K ﹤0.01% 665
2023
Q2
$2.2K Buy
27
+3
+13% +$241 ﹤0.01% 685
2023
Q1
$1.78K Sell
24
-12
-33% -$925 ﹤0.01% 662
2022
Q4
$2.98K Hold
36
﹤0.01% 1165
2022
Q3
$2.56K Buy
36
+28
+350% +$2.42K ﹤0.01% 1160
2022
Q2
$693 Buy
8
+4
+100% +$375 ﹤0.01% 1382
2022
Q1
$433 Sell
4
-48
-92% -$4.95K ﹤0.01% 1504
2021
Q4
$6.72K Buy
+52
New +$6.38K ﹤0.01% 1029

Other funds holding TECH

Sutton Wealth Advisors's TECH Position: Q3 2023 in Review

Sutton Wealth Advisors increased its Bio-Techne (TECH) stake by 59% in Q3 2023, buying an estimated $1.26K and bringing the position to 43 shares worth $2.93K. The position accounts for ﹤0.01% of the portfolio, ranked #665.

Sutton Wealth Advisors first reported a position in TECH in Q4 2021 and has held it in 8 quarters since. The position peaked at $6.72K in Q4 2021. 530 funds tracked by Wall St. Rank hold TECH as of Q3 2023.

  • Sutton Wealth Advisors held 43 shares of Bio-Techne worth $2.93K as of Q3 2023.
  • Sutton Wealth Advisors bought 16 Bio-Techne shares in Q3 2023, an estimated $1.26K.
  • Bio-Techne made up ﹤0.01% of Sutton Wealth Advisors's portfolio in Q3 2023, its #665 holding.
  • Sutton Wealth Advisors first reported a position in Bio-Techne in Q4 2021 and has held it in 8 quarters since.
  • Sutton Wealth Advisors's Bio-Techne position peaked at $6.72K in Q4 2021.
  • 530 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2023.

Based on Sutton Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.